Among insured patients with type 2 diabetes, copayments and glycosylated hemoglobin values were associated with increased rates of drug switching.
Marjorie K. Mau, MD
Advertisement
Articles by Marjorie K. Mau, MD
Advertisement
Latest Updated Articles
- Copayment Level and Drug Switching: Findings for Type 2 Diabetes
January 7th 2011
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Brain Inflammation May Not Drive Persistent Long COVID Symptoms, New Imaging Study Finds
3
Beyond Weight Loss: Exploring the Renal and Anti-Inflammatory Benefits of High-Dose Semaglutide
4
Adults With Schizophrenia Remain Stable When Transitioning from Atypical Antipsychotic to Cobenfy
5